Effects of synbiotic supplementation on energy and macronutrients homeostasis and muscle wasting of critical care patients: study protocol and a review of previous studies
Background: Among critically ill patients, regardless of the heterogeneity of disease state, an extreme and persistent dysbiosis occurs. Dysbiosis in critically ill patients may make them prone to hospital-acquired infections, sepsis, multi-organ failure (MOF), energy homeostasis disturbance, muscle wasting, and cachexia. Modulation of gut microbiota through synbiotics can be considered as a potential treatment for muscle wasting and macronutrients homeostasis disturbances.
Methods: This is a prospective, single center, double-blind; a parallel randomized controlled trial that aimed to evaluate the effects of synbiotic supplementation on energy and macronutrient homeostasis and muscle wasting in critical care patients. A total of 40 hemodynamically- stable adult critically ill patients who receive enteral nutrition via nasogasteric tube (NGT) in the 24-48h after admission will be included in this study. Eligible patients will be randomly assigned to receive Lactocare (ZistTakhmir) capsules 500 mg every 12h or a placebo capsule which contains only the sterile maize starch and is similar to synbiotic capsules for 14 days. The synbiotic and placebo capsules will be given through nasogastric tube, separately from gavage, after feeding.
Discussion: Gut microbiota modulation through synbiotics is proposed to improve clinical prognosis and reduce infectious complications, ventilator dependency and ICU stay by improving energy and macronutrient homeostasis and reducing muscle protein catabolism.
Figure 1
Figure 2
Figure 3
This is a list of supplementary files associated with this preprint. Click to download.
Posted 20 Jan, 2020
On 24 Feb, 2020
On 03 Feb, 2020
Invitations sent on 20 Jan, 2020
On 20 Jan, 2020
On 20 Jan, 2020
Received 20 Jan, 2020
Received 20 Jan, 2020
On 16 Jan, 2020
On 15 Jan, 2020
On 05 Jan, 2020
Received 24 Dec, 2019
Received 23 Dec, 2019
Received 23 Dec, 2019
On 17 Dec, 2019
On 16 Dec, 2019
On 16 Dec, 2019
Invitations sent on 15 Dec, 2019
On 26 Nov, 2019
On 25 Nov, 2019
On 17 Nov, 2019
On 24 Oct, 2019
On 17 Oct, 2019
On 01 Oct, 2019
Effects of synbiotic supplementation on energy and macronutrients homeostasis and muscle wasting of critical care patients: study protocol and a review of previous studies
Posted 20 Jan, 2020
On 24 Feb, 2020
On 03 Feb, 2020
Invitations sent on 20 Jan, 2020
On 20 Jan, 2020
On 20 Jan, 2020
Received 20 Jan, 2020
Received 20 Jan, 2020
On 16 Jan, 2020
On 15 Jan, 2020
On 05 Jan, 2020
Received 24 Dec, 2019
Received 23 Dec, 2019
Received 23 Dec, 2019
On 17 Dec, 2019
On 16 Dec, 2019
On 16 Dec, 2019
Invitations sent on 15 Dec, 2019
On 26 Nov, 2019
On 25 Nov, 2019
On 17 Nov, 2019
On 24 Oct, 2019
On 17 Oct, 2019
On 01 Oct, 2019
Background: Among critically ill patients, regardless of the heterogeneity of disease state, an extreme and persistent dysbiosis occurs. Dysbiosis in critically ill patients may make them prone to hospital-acquired infections, sepsis, multi-organ failure (MOF), energy homeostasis disturbance, muscle wasting, and cachexia. Modulation of gut microbiota through synbiotics can be considered as a potential treatment for muscle wasting and macronutrients homeostasis disturbances.
Methods: This is a prospective, single center, double-blind; a parallel randomized controlled trial that aimed to evaluate the effects of synbiotic supplementation on energy and macronutrient homeostasis and muscle wasting in critical care patients. A total of 40 hemodynamically- stable adult critically ill patients who receive enteral nutrition via nasogasteric tube (NGT) in the 24-48h after admission will be included in this study. Eligible patients will be randomly assigned to receive Lactocare (ZistTakhmir) capsules 500 mg every 12h or a placebo capsule which contains only the sterile maize starch and is similar to synbiotic capsules for 14 days. The synbiotic and placebo capsules will be given through nasogastric tube, separately from gavage, after feeding.
Discussion: Gut microbiota modulation through synbiotics is proposed to improve clinical prognosis and reduce infectious complications, ventilator dependency and ICU stay by improving energy and macronutrient homeostasis and reducing muscle protein catabolism.
Figure 1
Figure 2
Figure 3